SLC1A2 and nonpapillary renal cell carcinoma: Neither SLC7A11 nor SLC1A2 mRNA levels were affected by HIF activation in Hep3B cells or ccRCC cells, and inhibitors of the cystine/glutamate antiporter or vesicular glutamate transporter activity had no effect on extracellular glutamate concentration in 786-O cells, excluding their contribution to HIF-mediated glutamate release in these cells.